4/A: Viemed Healthcare COO Amends SEC Filing After Stock Unit Vesting
SEC Form 4 Amendment
Viemed Healthcare's Chief Operating Officer, William Todd Zehnder, amended a previous SEC filing to reflect the withholding of shares for tax obligations related to the vesting of restricted stock units.
Summary
- William Todd Zehnder, Chief Operating Officer of Viemed Healthcare, amended a previous SEC Form 4 filing.
- The amendment reflects the withholding of 5,761 common shares to cover tax liabilities associated with the vesting of 18,979 restricted stock units (RSUs) on January 18, 2025.
- The original filing was made on January 22, 2025.
- Following the transaction, Zehnder directly owns 255,277 common shares.
- The price per share for the tax withholding was $8.15, based on the market closing price on January 17, 2025.
- The RSUs were granted on January 18, 2022, and vest in three equal annual installments.
Sentiment
Score: 7
Explanation: The document is a routine SEC filing related to executive compensation. It does not indicate any positive or negative news for the company, but it is a normal part of operations.
Industry Context
This is a routine filing related to executive compensation and is common for publicly traded companies. It reflects the standard practice of withholding shares to cover tax obligations when stock options or restricted stock units vest.
Comparison to Industry Standards
- The vesting of restricted stock units and the subsequent tax withholding are standard practices in executive compensation across publicly traded companies.
- Many companies use a similar approach to manage tax obligations for their employees who receive equity-based compensation.
- The use of market closing price on the day prior to the vesting date is a common method for determining the value of shares for tax purposes.
Stakeholder Impact
- The transaction has a minor impact on shareholders as it involves a small number of shares being withheld for tax purposes.
- The transaction is part of the standard compensation package for the COO.
Key Dates
| Date | Description |
|---|---|
| 01/18/2022 | Date the Restricted Stock Units (RSUs) were granted to the reporting person. |
| 01/17/2025 | Date used to determine the market closing price of common shares for tax withholding. |
| 01/18/2025 | Date of the vesting of restricted stock units and the related tax withholding. |
| 01/22/2025 | Date of the original Form 4 filing that was amended. |
| 01/23/2025 | Date of the amended filing. |
Keywords
SEC Filing, Form 4, Viemed Healthcare, Restricted Stock Units, Stock Vesting, Tax Withholding, Beneficial Ownership, Insider Trading
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.